• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Vanda Pharmaceuticals

bad sleep sleep disorder timeline alarm clock deadline
Pharma

Vanda eyes expansion prospect for Hetlioz outside jet lag

Vanda's melatonin receptor agonist Hetlioz has demonstrated its merit in another sleep indication with a current dearth of treatment options.
Fraiser Kansteiner Sep 30, 2026 11:13am
The Vanda Nereus-branded No 47 IndyCar

Vanda shifts into high gear with Schumacher IndyCar sponsorship

Jul 16, 2026 1:13pm
motion sickness

Vanda tests motion sickness drug Nereus in GLP-1 patients

Apr 9, 2026 2:56pm
FDA

Vanda secures long-awaited FDA hearing in jet lag approval bid

Mar 4, 2026 3:22pm
green light go go ahead advance yes streetlight

FDA signs off on Vanda's Bysanti for schizophrenia and bipolar I

Feb 23, 2026 11:35am
jet lag sleep disorder

FDA rejects Vanda's Hetlioz for a 2nd time in jet lag disorder

Jan 8, 2026 11:20am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings